Showing results (481-490 of 527) with videos related to

Sort By:
Pageof 53
JTO Clinical and Research Reports|September 30, 2021
Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural MesotheliomaKazuhiko Nakagawa, Takashi Kijima, Morihito Okada, et al.
Cancer Science|December 15, 2023
Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816Tetsuya Mitsudomi, Hiroyuki Ito, Morihito Okada, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 13, 2024
Early chest tube removal regardless of drainage volume after anatomic pulmonary resection: A multicenter, randomized, controlled trialKazuya Takamochi, Tomohiro Haruki, Shiaki Oh, et al.
Future Oncology (London, England)|September 27, 2024
Factors influencing decision-making between surgery and chemoradiotherapy for esophageal carcinoma from the JCOG0502Shun Yamamoto, Ken Kato, Hiroyuki Daiko, et al.
Clinical Lung Cancer|May 26, 2021
Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non-small-cell Lung Cancer: SQUAT trial (WJOG 12119L)Akira Hamada, Junichi Soh, Akito Hata, et al.
Breast Cancer (Tokyo, Japan)|April 3, 2021
Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study)Manabu Futamura, Mari Oba, Norikazu Masuda, et al.
Gastroenterology|August 14, 2021
Parallel-Group Controlled Trial of Surgery Versus Chemoradiotherapy in Patients With Stage I Esophageal Squamous Cell CarcinomaKen Kato, Yoshinori Ito, Isao Nozaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2021
Randomized Phase III Study of Gefitinib Versus Cisplatin Plus Vinorelbine for Patients With Resected Stage II-IIIA Non-Small-Cell Lung Cancer With EGFR Mutation (IMPACT)Hirohito Tada, Tetsuya Mitsudomi, Toshihiro Misumi, et al.
Translational Lung Cancer Research|April 15, 2026
Effectiveness and safety of combination immunotherapy with or without ipilimumab according to PD-L1 expression in patients with non-small cell lung cancer: a multi-center retrospective cohort studyAkio Nomura, Takeshi Masuda, Kiyofumi Shimoji, et al.
Lancet (London, England)|April 24, 2022
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trialHisashi Saji, Morihito Okada, Masahiro Tsuboi, et al.
Pageof 53